Danone (ENXTPA:BN) Stock Richly Valued Despite Strong Cash Flow And Margins

The market shrugged at Danone heading into these results. The stock drifted down about 4.7% over the past month and was roughly flat over the last week, even as expectations built around its premium valuation and health focused story.

Today’s half year numbers put profit quality back in the spotlight. Recurring operating margin reached 13.3% and free cash flow hit €0.9b, which matters more for a consumer staples group than headline growth alone. For a stock trading on a P/E of 22.6x, this earnings print is really about whether that cash generation still justifies the price tag.

Is Danone’s 22.6x P/E a sign the stock is richly priced, or is the market underestimating its cash generation and earnings forecasts? Compare the current market price to our valuation analysis for Danone

H1 2026 Earnings Summary

• Revenue H1 2026 vs H1 2025: €13,936m vs €13,737m (steady year on year)
• Net Income H1 2026 vs H1 2025: €1,166m vs €1,038m (higher year on year)
• Basic EPS H1 2026 vs H1 2025: €1.82 vs €1.61 (higher year on year)
• Recurring Operating Margin H1 2026 vs H1 2025: 13.3% vs 13.2% (slight improvement year on year)

Tired of scrolling through dense earnings tables and balance sheet figures? Get a clear visual view of Danone’s valuation with key charts that put today’s profit quality in context in the full company report for Danone.

Danone bull case leans on quality earnings progress

Bulls argue that Danone’s health focused portfolio and productivity push can lift recurring operating income faster than sales while keeping cash generation strong. H1 results give some backing to that view. Group like for like sales grew 3.5% in H1 and 4.2% in Q2, yet recurring operating margin ticked up to 13.3% and recurring EPS reached €1.92 with free cash flow at €0.9b. That is consistent with management’s 2026 framework for profit growing ahead of revenue. Category detail also lines up with the premium, science based story. Specialized Nutrition grew well in Medical Nutrition and is seeing infant milk formula recovery, while high protein and gut health platforms in Essential Dairy & Plant based, and the Made Group and Huel deals, all point to mix tilting toward higher value segments.

Bear case focuses on execution strain and mix risks

Bears worry that heavy exposure to traditional dairy and water, patchy execution in North America and integration risk from active M&A could cap earnings progress. H1 gives them some ammunition. Essential Dairy & Plant based margins were lower year on year despite Q2 like for like growth of 3.8%, which suggests inflation and pricing timing are still biting in a legacy heavy category. Waters grew 4.7% in Q2 but Mizone weakness in China shows how one brand can drag regional mix. Currency cut roughly 7% from EPS and inventory was built up, which needs to unwind cleanly. The Made Group, Huel, Kate Farms and Argentina dairy joint venture moves fit the portfolio story but also increase the execution bar. Recent 7 day and 30 day share price declines suggest the market is not treating this print as a clean win.

Compare whether Danone’s profit quality story lines up with institutional expectations. See the consensus price target analysis for Danone

Stay Ahead With Simply Wall St

If Danone’s mix of profit quality, free cash flow and premium P/E has you watching for a better entry point, register for free with Simply Wall St and add it to your Watchlist so you can track price against fair value and key earnings metrics in one place. After you own the stock, keep your decisions grounded in data by using the Portfolio Command Center to cut through market noise and surface only the most important updates on your holdings. For a wider view, tap into crowd insights and different angles on Danone and its peers through the Community. That combination may help you identify hidden catalysts and potential risks early so you can stay a step ahead in your research.

Curious About Alternatives Beyond Danone

Fresh ideas move first. Stocks with real breakout potential can start flying before the crowd notices and the best entry points get caught. Scan these curated lists and act now.

• Spot companies building momentum with resilient balance sheets and steady fundamentals by reviewing the curated list of solid balance sheet and fundamentals stocks (421 results). Do this while they remain under the radar for now.
• Chase high income opportunities with staying power by checking the curated 436 dividend fortresses before yields compress and prices move away from ideal entry zones.
• Track the next wave of automation leaders by scanning the curated 34 robotics and automation stocks while the story is still developing and expectations have not fully caught up.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com